Guidant's Acculink Is Exclusive CREST Stent; Trial Begins in Six Months
This article was originally published in The Gray Sheet
Executive Summary
Guidant has the option of evaluating an emboli protection device along with its Acculink self-expanding carotid stent in the 2,500-patient Carotid Revascularization Endarterectomy Stenting Trial (CREST), according to study investigators.